Jaw surgery pain study: which numbing drug works best?

NCT ID NCT06450028

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compared two common numbing drugs, lidocaine and bupivacaine, in 60 people aged 15–35 having jaw surgery. Researchers measured pain, numbness, and touch sensation after surgery. The goal is to find which drug gives patients a better recovery experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lidocaine and bupivacaine (local anesthetics)

What this could lead to

If this study shows one drug works better, surgeons may use it to reduce pain and numbness after jaw surgery.

What could go wrong

This is a small, completed Phase 4 trial with only 60 participants. Results may not apply to everyone, and both drugs are already standard care, so no major breakthrough is expected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypesthesia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States